0001415889-24-019279.txt : 20240703
0001415889-24-019279.hdr.sgml : 20240703
20240703193542
ACCESSION NUMBER: 0001415889-24-019279
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240702
FILED AS OF DATE: 20240703
DATE AS OF CHANGE: 20240703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Whiting Samuel
CENTRAL INDEX KEY: 0001870373
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35890
FILM NUMBER: 241101340
MAIL ADDRESS:
STREET 1: C/O TEMPEST THERAPEUTICS, INC.
STREET 2: 7000 SHORELINE COURT, SUITE 275
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tempest Therapeutics, Inc.
CENTRAL INDEX KEY: 0001544227
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 451472564
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY
STREET 2: SUITE 400
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 415-798-8589
MAIL ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY
STREET 2: SUITE 400
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: Millendo Therapeutics, Inc.
DATE OF NAME CHANGE: 20181207
FORMER COMPANY:
FORMER CONFORMED NAME: OvaScience, Inc.
DATE OF NAME CHANGE: 20120308
4
1
form4-07032024_110739.xml
X0508
4
2024-07-02
0001544227
Tempest Therapeutics, Inc.
TPST
0001870373
Whiting Samuel
C/O TEMPEST THERAPEUTICS, INC.
2000 SIERRA POINT PARKWAY, SUITE 400
BRISBANE
CA
94005
false
true
false
false
Chief Medical Officer
0
Common Stock
2024-07-02
4
P
0
4672
2.13
A
9573
D
Includes 3,000 shares acquired under the Issuer's stock purchase plan.
/s/ Nicholas Maestas, Attorney-in-Fact
2024-07-03